Europe Injection Pen Market Size & Outlook, 2025-2030
Related Markets
Europe injection pen market highlights
- The Europe injection pen market generated a revenue of USD 9,863.7 million in 2024.
- The market is expected to grow at a CAGR of 7.2% from 2025 to 2030.
- In terms of segment, reusable was the largest revenue generating product in 2024.
- Reusable is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 9,863.7 million |
| Market revenue in 2030 | USD 14,986.6 million |
| Growth rate | 7.2% (CAGR from 2025 to 2030) |
| Largest segment | Reusable |
| Fastest growing segment | Reusable |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable, Reusable |
| Key market players worldwide | BD, Eli Lilly and Co, Ypsomed Holding AG, Biocon, Pfizer Inc, Novartis AG ADR, Novo Nordisk A/S ADR, Sanofi SA, Owen Mumford, Merck KGaA |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.7% of the global injection pen market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 13,192.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Injection Pen Market Scope
Injection Pen Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Owen Mumford | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.owenmumford.com/en/ |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Europe injection pen market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to injection pen market will help companies and investors design strategic landscapes.
Reusable was the largest segment with a revenue share of 70.39% in 2024. Horizon Databook has segmented the Europe injection pen market based on disposable, reusable covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe injection pen market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe injection pen market databook
-
Our clientele includes a mix of injection pen market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe injection pen market , including forecasts for subscribers. This continent databook contains high-level insights into Europe injection pen market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe injection pen market size, by country, 2018-2030 (US$M)
Europe Injection Pen Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
